Cargando…
Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia
BACKGROUND: In Jimma Zone, Ethiopia, the first-line treatment of uncomplicated falciparum malaria has been changed from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (AL) in 2006. The objective of this study was to assess the effectiveness of AL in Jimma Zone two to three years after it...
Autores principales: | Eshetu, Teferi, Abdo, Nasir, Bedru, Kunuz H, Fekadu, Sintayehu, Wieser, Andreas, Pritsch, Michael, Löscher, Thomas, Berens-Riha, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438107/ https://www.ncbi.nlm.nih.gov/pubmed/22824059 http://dx.doi.org/10.1186/1475-2875-11-240 |
Ejemplares similares
-
Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial
por: Gürkov, Robert, et al.
Publicado: (2008) -
Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia
por: Eshetu, Teferi, et al.
Publicado: (2010) -
Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009) -
Evaluation of Plasmodium falciparum gametocyte detection in different patient material
por: Kast, Katharina, et al.
Publicado: (2013) -
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India
por: Valecha, Neena, et al.
Publicado: (2009)